Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00378638
Recruitment Status : Unknown
Verified October 2007 by Chap, Linnea I., M.D..
Recruitment status was:  Recruiting
First Posted : September 20, 2006
Last Update Posted : October 24, 2007
Genentech, Inc.
Information provided by:
Chap, Linnea I., M.D.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : October 2008